Liver Cirrhoses: Clinical Trials

5 trials for Liver Cirrhoses, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 recruiting, 2 terminated, 1 completed. 5 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 45Recruiting 2, Terminated 2, Completed 1

Follow Liver Cirrhoses: new trials by email Literature Review of Liver Cirrhoses trials Research Report on Liver Cirrhoses

Trials (filtered) newest first · largest first

All 5 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Optimizing Portal Hypertension With TIPS and Interval Metabolic Surgery for Advanced Liver Disease
Transjugular Intrahepatic Portosystemic Shunt (TIPS), Sleeve Gastrectomy, Anti-Obesity Pharmacotherapy (Class Effect) - Liver Cirrhoses, Portal Hypertension Related to Cirrhosis
Phase 4RecruitingThe Cleveland Clinic702025-12-172026-10-22
Statins for Prevention of Disease Progression and Hospitalization in Liver Cirrhosis
Placebo oral tablet, Atorvastatin 10mg - Liver Cirrhoses
Phase 4TerminatedCopenhagen University Hospital, Hvidovre782019-11-082023-01-13
Comparison of 24-hours Versus 72-hours of Octreotide Infusion in Preventing Early Rebleed From Esophageal Varices
Octreotide - Esophageal Varices, Liver Cirrhoses
Phase 4TerminatedMedical University of South Carolina342018-09-192025-11-20
Gadolinium Contrast-enhanced Abbreviated MRI (AMRI) vs. Standard Ultrasound for Hepatocellular Carcinoma (HCC) Surveillance in Patients With Cirrhosis
Gadolinium ethoxybenzyl diethylenetriamine pentaacetic acid - Liver Cancer, Liver Cirrhoses
Phase 4CompletedUniversity of California, San Diego792018-04-272026-02-12
Antibiotic Prophylaxis in Patients Undergoing GVO
Ertapenem - Gastric Varix, Sepsis
Phase 4RecruitingTaipei Veterans General Hospital, Taiwan1502017-01-282019-10-28

Narrower conditions

Esophageal and Gastric Varices (2)  ·  Carcinoma, Hepatocellular (1)  ·  Fever (1)  ·  Gastrointestinal Hemorrhage (1)  ·  Liver Neoplasms (1)  ·  Obesity, Morbid (1)  ·  Sepsis (1)  ·  Weight Loss (1)

Broader conditions

Digestive System Diseases (3)  ·  Liver Diseases (3)  ·  Pathological Conditions, Signs and Symptoms (3)  ·  Esophageal Diseases (2)  ·  Gastrointestinal Diseases (2)  ·  Hypertension, Portal (2)  ·  Pathologic Processes (2)  ·  Signs and Symptoms (2)  ·  Adenocarcinoma (1)  ·  Body Temperature Changes (1)  ·  Body Weight (1)  ·  Body Weight Changes (1)  ·  Carcinoma (1)  ·  Digestive System Neoplasms (1)  ·  Hemorrhage (1)

Interventions

Atorvastatin (1)  ·  Diet Therapy (1)  ·  Ertapenem (1)  ·  Glucagon-Like Peptide-1 Receptor Agonists (1)  ·  Octreotide (1)  ·  Phentermine (1)  ·  Portasystemic Shunt, Transjugular Intrahepatic (1)  ·  Topiramate (1)  ·  gadolinium ethoxybenzyl DTPA (1)

Sponsors

Copenhagen University Hospital, Hvidovre (1)  ·  Medical University of South Carolina (1)  ·  Taipei Veterans General Hospital, Taiwan (1)  ·  The Cleveland Clinic (1)  ·  University of California, San Diego (1)

Countries

United States (3)  ·  Denmark (1)  ·  Taiwan (1)

Top investigators

Ali Aminian, MD (1)  ·  Claude B Sirlin, MD (1)  ·  Don Rockey, M.D (1)  ·  Flemming Bendtsen, DmSci (1)  ·  Ming-Chih Hou (1)  ·  Thit M Kronborg, MD (1)

Results publications

PMID 11864921, PMID 31980514, PMID 39241828